Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.13 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket: tofersen | 0.60 |
| trials ClinicalTrials.gov | 5 Parkinson's trials, 0 stopped | 1.00 |
| literature PubMed | 404 Parkinson's papers of 11,822 | 0.21 |
| pathways Reactome | 3 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 2286
Sealed predictions
- SOD1 in dopamine neurons, braak+0.50 (p 0.173) → +0.02 (p 0.965)receipt 2293
Swarm cases
receipt 2293: SOD1 in dopamine neurons, braak
- power
- full sample +0.31 (p 0.211, n 18), 95% CI -0.18 to +0.68. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.32 (p 0.194, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.30 (p 0.225, n 18). could be the mix.
- skeptic
- leave-one-out range +0.22 to +0.48, sign flips 0; without severely affected donors +0.31 (p 0.211, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SOD1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts